|
|
|
Alzheimer Disease Clinical Trials |
|
Thank you for your interest in clinical trials for Alzheimer Disease
Please click "Search" to find Alzheimer Disease clinical trials and medical research studies.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 14 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's - NCT01148498-63108
Conditions: Alzheimer's Disease
Location: St. Louis, MO
- A Comparison of Two Standard Therapies in the Management of Dementia With Agitation - NCT00208819-30329
Conditions: Senile Dementia, Alzheimer Type - Dementia, Alzheimer Type - Alzheimer Disease - Dementia
Location: Atlanta, GA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-02115
Conditions: Alzheimer's Disease
Location: Boston, MA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-02906
Conditions: Alzheimer's Disease
Location: Providence, RI
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-06360
Conditions: Alzheimer's Disease
Location: Norwich, CT
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-06510
Conditions: Alzheimer's Disease
Location: New Haven, CT
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-07724
Conditions: Alzheimer's Disease
Location: Eatontown, NJ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-08540
Conditions: Alzheimer's Disease
Location: Princeton, NJ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-08755
Conditions: Alzheimer's Disease
Location: Toms River, NJ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-08903
Conditions: Alzheimer's Disease
Location: New Brunswick, NJ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-10016
Conditions: Alzheimer's Disease
Location: New York, NY
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-10032
Conditions: Alzheimer's Disease
Location: New York, NY
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-11235
Conditions: Alzheimer's Disease
Location: Brooklyn, NY
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-14620
Conditions: Alzheimer's Disease
Location: Rochester, NY
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-27103
Conditions: Alzheimer's Disease
Location: Winston Salem, NC
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-27157
Conditions: Alzheimer's Disease
Location: Winston-Salem, NC
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-27607
Conditions: Alzheimer's Disease
Location: Raleigh, NC
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-27609
Conditions: Alzheimer's Disease
Location: Raleigh, NC
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-27710
Conditions: Alzheimer's Disease
Location: Durham, NC
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-32224
Conditions: Alzheimer's Disease
Location: Jacksonville, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-32806
Conditions: Alzheimer's Disease
Location: Orlando, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-33009
Conditions: Alzheimer's Disease
Location: Hallandale Beach, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-33143
Conditions: Alzheimer's Disease
Location: South Miami, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-33445
Conditions: Alzheimer's Disease
Location: Delray Beach, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-33613
Conditions: Alzheimer's Disease
Location: Tampa, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-34601
Conditions: Alzheimer's Disease
Location: Brooksville, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-35294
Conditions: Alzheimer's Disease
Location: Birmingham, AL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-42003
Conditions: Alzheimer's Disease
Location: Paducah, KY
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-43210
Conditions: Alzheimer's Disease
Location: Columbus, OH
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-43623
Conditions: Alzheimer's Disease
Location: Toledo, OH
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-46202
Conditions: Alzheimer's Disease
Location: Indianapolis, IN
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-53226
Conditions: Alzheimer's Disease
Location: Milwaukee, WI
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-53562
Conditions: Alzheimer's Disease
Location: Middleton, WI
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-63104
Conditions: Alzheimer's Disease
Location: St Louis, MO
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-63108
Conditions: Alzheimer's Disease
Location: St. Louis, MO
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-74104
Conditions: Alzheimer's Disease
Location: Tulsa, OK
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-75390
Conditions: Alzheimer's Disease
Location: Dallas, TX
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-78757
Conditions: Alzheimer's Disease
Location: Austin, TX
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-80239
Conditions: Alzheimer's Disease
Location: Denver, CO
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-85004
Conditions: Alzheimer's Disease
Location: Phoenix, AZ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-85006
Conditions: Alzheimer's Disease
Location: Phoenix, AZ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-85351
Conditions: Alzheimer's Disease
Location: Sun City, AZ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-85381
Conditions: Alzheimer's Disease
Location: Peoria, AZ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-89106
Conditions: Alzheimer's Disease
Location: Las Vegas, NV
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-90095
Conditions: Alzheimer's Disease
Location: Los Angeles, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-91403
Conditions: Alzheimer's Disease
Location: Sherman Oaks, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-92037
Conditions: Alzheimer's Disease
Location: La Jolla, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-92103
Conditions: Alzheimer's Disease
Location: San Diego, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-92108
Conditions: Alzheimer's Disease
Location: San Diego, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-92660
Conditions: Alzheimer's Disease
Location: Newport Beach, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-92845
Conditions: Alzheimer's Disease
Location: Garden Grove, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-92868
Conditions: Alzheimer's Disease
Location: Orange, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-93720
Conditions: Alzheimer's Disease
Location: Fresno, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-97225
Conditions: Alzheimer's Disease
Location: Portland, OR
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-97239
Conditions: Alzheimer's Disease
Location: Portland, OR
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-98108
Conditions: Alzheimer's Disease
Location: Seattle, WA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-01805
Conditions: Alzheimer´s Disease
Location: Burlington, MA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-02903
Conditions: Alzheimer´s Disease
Location: Providence, RI
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-06510
Conditions: Alzheimer´s Disease
Location: New Haven, CT
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-10016
Conditions: Alzheimer´s Disease
Location: New York, NY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-10021
Conditions: Alzheimer´s Disease
Location: New York, NY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-10029
Conditions: Alzheimer´s Disease
Location: New York, NY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-10032
Conditions: Alzheimer´s Disease
Location: New York, NY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-13088
Conditions: Alzheimer´s Disease
Location: Liverpool, NY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-14620
Conditions: Alzheimer´s Disease
Location: Rochester, NY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-19104
Conditions: Alzheimer´s Disease
Location: Philadelphia, PA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-20057
Conditions: Alzheimer´s Disease
Location: Washington, DC
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-20060
Conditions: Alzheimer´s Disease
Location: Washington, DC
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-29406
Conditions: Alzheimer´s Disease
Location: N. Charleston, SC
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-33140
Conditions: Alzheimer´s Disease
Location: Miami Beach, FL
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-33613
Conditions: Alzheimer´s Disease
Location: Tampa, FL
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-34243
Conditions: Alzheimer´s Disease
Location: Sarasota, FL
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-35294
Conditions: Alzheimer´s Disease
Location: Birmingham, AL
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-37067
Conditions: Alzheimer´s Disease
Location: Franklin, TN
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-40536
Conditions: Alzheimer´s Disease
Location: Lexington, KY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-44122
Conditions: Alzheimer´s Disease
Location: Beachwood, OH
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-49079
Conditions: Alzheimer´s Disease
Location: Paw Paw, MI
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-52242
Conditions: Alzheimer´s Disease
Location: Iowa City, IA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-53705
Conditions: Alzheimer´s Disease
Location: Madison, WI
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-55905
Conditions: Alzheimer´s Disease
Location: Rochester, MN
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-63104
Conditions: Alzheimer´s Disease
Location: St. Louis, MO
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-66160
Conditions: Alzheimer´s Disease
Location: Kansas City, KS
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-68198
Conditions: Alzheimer´s Disease
Location: Omaha, NE
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-75390
Conditions: Alzheimer´s Disease
Location: Dallas, TX
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-84108
Conditions: Alzheimer´s Disease
Location: Salt Lake City, UT
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-85006
Conditions: Alzheimer´s Disease
Location: Phoenix, AZ
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-85351
Conditions: Alzheimer´s Disease
Location: Sun City, AZ
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-85724
Conditions: Alzheimer´s Disease
Location: Tucson, AZ
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-89106
Conditions: Alzheimer´s Disease
Location: Las Vegas, NV
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-90033
Conditions: Alzheimer´s Disease
Location: Los Angeles, CA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-92093
Conditions: Alzheimer´s Disease
Location: La Jolla, CA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-92697
Conditions: Alzheimer´s Disease
Location: Irvine, CA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-92868
Conditions: Alzheimer´s Disease
Location: Orange, CA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-97201
Conditions: Alzheimer´s Disease
Location: Portland, OR
- A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease - NCT01122329-90095A
Conditions: Alzheimer Disease
Location: Los Angeles, CA
- A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease - NCT01122329-90095B
Conditions: Alzheimer Disease
Location: Los Angeles, CA
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease - NCT00235716-02130
Conditions: Alzheimer's Disease
Location: Boston, MA
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease - NCT00235716-21201
Conditions: Alzheimer's Disease
Location: Baltimore, MD
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease - NCT00235716-29401
Conditions: Alzheimer's Disease
Location: Charleston, SC
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease - NCT00235716-33125
Conditions: Alzheimer's Disease
Location: Miami, FL
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease - NCT00235716-33708
Conditions: Alzheimer's Disease
Location: Bay Pines, FL
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease - NCT00235716-44106
Conditions: Alzheimer's Disease
Location: Cleveland, OH
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease - NCT00235716-48113
Conditions: Alzheimer's Disease
Location: Ann Arbor, MI
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease - NCT00235716-52246
Conditions: Alzheimer's Disease
Location: Iowa City, IA
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease - NCT00235716-53705
Conditions: Alzheimer's Disease
Location: Madison, WI
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease - NCT00235716-55417
Conditions: Alzheimer's Disease
Location: Minneapolis, MN
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease - NCT00235716-75216
Conditions: Alzheimer's Disease
Location: Dallas, TX
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease - NCT00235716-98108
Conditions: Alzheimer's Disease
Location: Seattle, WA
- A Safety Study of LY2886721 Single Doses in Healthy Subjects - NCT01133405-90211
Conditions: Alzheimer's Disease
Location: Beverly Hills, CA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-01805
Conditions: Alzheimer's Disease
Location: Burlington, MA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-02118
Conditions: Alzheimer's Disease
Location: Boston, MA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-02601
Conditions: Alzheimer's Disease
Location: Hyannis, MA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-02914
Conditions: Alzheimer's Disease
Location: East Providence, RI
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-05201
Conditions: Alzheimer's Disease
Location: Bennington, VT
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-06510
Conditions: Alzheimer's Disease
Location: New Haven, CT
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-06518
Conditions: Alzheimer's Disease
Location: Hamden, CT
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-10032
Conditions: Alzheimer's Disease
Location: New York, NY
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-11030
Conditions: Alzheimer's Disease
Location: Manhasset, NY
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-12208
Conditions: Alzheimer's Disease
Location: Albany, NY
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-15261
Conditions: Alzheimer's Disease
Location: Pittsburgh, PA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-19046
Conditions: Alzheimer's Disease
Location: Jenkintown, PA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-19104
Conditions: Alzheimer's Disease
Location: Philadelphia, PA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-20057
Conditions: Alzheimer's Disease
Location: Washington, DC
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-21224
Conditions: Alzheimer's Disease
Location: Baltimore, MD
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-27103
Conditions: Alzheimer's Disease
Location: Winston-Salem, NC
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-27607
Conditions: Alzheimer's Disease
Location: Raleigh, NC
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-27710
Conditions: Alzheimer's Disease
Location: Durham, NC
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-29406
Conditions: Alzheimer's Disease
Location: North Charleston, SC
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-32806
Conditions: Alzheimer's Disease
Location: Orlando, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-33021
Conditions: Alzheimer's Disease
Location: Hollywood, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-33064
Conditions: Alzheimer's Disease
Location: Deerfield Beach, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-33140
Conditions: Alzheimer's Disease
Location: Miami, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-33308
Conditions: Alzheimer's Disease
Location: Fort Lauderdale, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-33351
Conditions: Alzheimer's Disease
Location: Sunrise, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-33407
Conditions: Alzheimer's Disease
Location: West Palm Beach, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-33431
Conditions: Alzheimer's Disease
Location: Boca Raton, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-33613A
Conditions: Alzheimer's Disease
Location: Tampa, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-33613B
Conditions: Alzheimer's Disease
Location: Tampa Bay, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-33716
Conditions: Alzheimer's Disease
Location: St Petersburg, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-33912
Conditions: Alzheimer's Disease
Location: Fort Myers, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-34601
Conditions: Alzheimer's Disease
Location: Brooksville, FL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-35294
Conditions: Alzheimer's Disease
Location: Birmingham, AL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-39401
Conditions: Alzheimer's Disease
Location: Hattiesburg, MS
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-40503
Conditions: Alzheimer's Disease
Location: Lexington, KY
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-43210
Conditions: Alzheimer's Disease
Location: Columbus, OH
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-43623
Conditions: Alzheimer's Disease
Location: Toledo, OH
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-46202
Conditions: Alzheimer's Disease
Location: Indianapolis, IN
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-53705
Conditions: Alzheimer's Disease
Location: Madison, WI
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-60601
Conditions: Alzheimer's Disease
Location: Chicago, IL
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-63108
Conditions: Alzheimer's Disease
Location: St Louis, MO
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-68198
Conditions: Alzheimer's Disease
Location: Omaha, NE
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-70131
Conditions: Alzheimer's Disease
Location: New Orleans, LA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-71104
Conditions: Alzheimer's Disease
Location: Shreveport, LA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-73116
Conditions: Alzheimer's Disease
Location: Oklahoma City, OK
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-84108
Conditions: Alzheimer's Disease
Location: Salt Lake City, UT
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-85006
Conditions: Alzheimer's Disease
Location: Phoenix, AZ
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-85351
Conditions: Alzheimer's Disease
Location: Sun City, AZ
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-85741
Conditions: Alzheimer's Disease
Location: Tucson, AZ
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-90404
Conditions: Alzheimer's Disease
Location: Santa Monica, CA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-90717
Conditions: Alzheimer's Disease
Location: Lomita, CA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-92037
Conditions: Alzheimer's Disease
Location: La Jolla, CA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-92103
Conditions: Alzheimer's Disease
Location: San Diego, CA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-92626
Conditions: Alzheimer's Disease
Location: Costa Mesa, CA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-92653
Conditions: Alzheimer's Disease
Location: Laguna Hills, CA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-92868
Conditions: Alzheimer's Disease
Location: Orange, CA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-93030
Conditions: Alzheimer's Disease
Location: Oxnard, CA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-93720
Conditions: Alzheimer's Disease
Location: Fresno, CA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-95817
Conditions: Alzheimer's Disease
Location: Sacramento, CA
- A Study in Semagacestat for Alzheimer's Patients - NCT01035138-97401
Conditions: Alzheimer's Disease
Location: Eugene, OR
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-06851
Conditions: Alzheimer Disease
Location: Norwalk, CT
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-07724
Conditions: Alzheimer Disease
Location: Eatontown, NJ
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-10605
Conditions: Alzheimer Disease
Location: White Plains, NY
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-32751
Conditions: Alzheimer Disease
Location: Maitland, FL
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-33445
Conditions: Alzheimer Disease
Location: Delray Beach, FL
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-33613
Conditions: Alzheimer Disease
Location: Tampa, FL
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-33912
Conditions: Alzheimer Disease
Location: Ft. Myers, FL
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-42003
Conditions: Alzheimer Disease
Location: Paducah, KY
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-49048
Conditions: Alzheimer Disease
Location: Kalamazoo, MI
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-63044
Conditions: Alzheimer Disease
Location: St. Louis, MO
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-87109
Conditions: Alzheimer Disease
Location: Albuquerque, NM
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-92701
Conditions: Alzheimer Disease
Location: Santa Ana, CA
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-92845
Conditions: Alzheimer Disease
Location: Garden Grove, CA
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease - NCT00884507-97210
Conditions: Alzheimer Disease
Location: Portland, OR
- Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals - NCT00855868-19104
Conditions: Alzheimer's Disease
Location: Philadelphia, PA
- Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease - NCT01082965-19104
Conditions: Alzheimer's Disease
Location: Philadelphia, PA
- Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease - NCT01082965-63108
Conditions: Alzheimer's Disease
Location: St. Louis, MO
- Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease - NCT01082965-63110
Conditions: Alzheimer's Disease
Location: St. Louis, MO
- Alzheimer's Disease Genetics Study - NCT00064870-
Conditions: Alzheimer Disease - Late Onset Alzheimer Disease
Location: Nationwide, IN
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-02115
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Boston, MA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-02118
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Boston, MA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-02903
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Providence, RI
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-02906
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Providence, RI
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-03756
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Lebanon, NH
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-06106
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Hartford, CT
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-06510
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: New Haven, CT
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-10016
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: New York, NY
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-10029
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: New York, NY
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-10032
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: New York, NY
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-12208
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Albany, NY
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-14226
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Amherst, NY
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-14620
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Rochester, NY
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-15213
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Pittsburgh, PA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-19104
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Philadelphia, PA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-20057
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Washington, DC
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-20060
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Washington, DC
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-21205
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Baltimore, MD
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-27157
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Winston-Salem, NC
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-27710
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Durham, NC
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-29406
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Charleston, SC
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-30329
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Atlanta, GA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-32224
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Jacksonville, FL
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-33140
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Miami, FL
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-33407
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: West Palm Beach, FL
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-35294
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Birmingham, AL
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-40536
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Lexington, KY
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-43210
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Columbus, OH
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-44122
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Cleveland, OH
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-46202
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Indianapolis, IN
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-48109
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Ann Arbor, MI
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-53705
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Madison, WI
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-55901
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Rochester, MN
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-60611
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Chicago, IL
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-60612
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Chicago, IL
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-63108
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: St. Louis, MO
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-66160
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Kansas City, KS
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-75390
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Dallas, TX
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-77030
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Houston, TX
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-85006
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Phoenix, AZ
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-85351
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Sun City, AZ
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-89106
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Las Vegas, NV
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-90033
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Los Angeles, CA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-90095
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Los Angeles, CA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-92037
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: San Diego, CA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-92697
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Irvine, CA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-92868
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Irvine, CA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-94143
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: San Francisco, CA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-94304
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Palo Alto, CA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-94553
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Martinez, CA
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity - NCT01078636-97239
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Portland, OR
- Alzheimer's in Long-Term Care--Treatment for Agitation - NCT00161473-98108
Conditions: Alzheimer Disease - Psychomotor Agitation
Location: Seattle, WA
- Amyloid Plaque and Tangle Imaging in Aging and Dementia - NCT00355498-90024
Conditions: Memory Disorders - Alzheimer's Disease
Location: Los Angeles, CA
- Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome - NCT00965835-90024
Conditions: Down Syndrome - Alzheimer's Disease
Location: Los Angeles, CA
- An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease - NCT01013610-32809
Conditions: Mild Alzheimer's Disease
Location: Orlando, FL
- An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease - NCT00409279-10016
Conditions: Alzheimer Disease
Location: New York, NY
- Apathy in Dementia Methylphenidate Trial (ADMET) - NCT01117181-21224
Conditions: Apathy - Alzheimer's Disease
Location: Baltimore, MD
- Apathy in Dementia Methylphenidate Trial (ADMET) - NCT01117181-29406
Conditions: Apathy - Alzheimer's Disease
Location: Charleston, SC
- Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease - NCT01028053-08540
Conditions: Mild Cognitive Impairment - Alzheimer's Disease
Location: Princeton, NJ
- Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) - NCT00575055-01201
Conditions: Alzheimer's Disease
Location: Pittsfield, MA
- Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) - NCT00575055-01830
Conditions: Alzheimer's Disease
Location: Haverhill, MA
- Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) - NCT00575055-02115
Conditions: Alzheimer's Disease
Location: Boston, MA
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|